These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1121 related items for PubMed ID: 19019456
1. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Figueiredo MD, Vandenplas ML, Hurley DJ, Moore JN. Vet Immunol Immunopathol; 2009 Jan 15; 127(1-2):125-34. PubMed ID: 19019456 [Abstract] [Full Text] [Related]
4. Differential induction of Toll-like receptor gene expression in equine monocytes activated by Toll-like receptor ligands or TNF-α. Kwon S, Vandenplas ML, Figueiredo MD, Salter CE, Andrietti AL, Robertson TP, Moore JN, Hurley DJ. Vet Immunol Immunopathol; 2010 Dec 01; 138(3):213-7. PubMed ID: 20801527 [Abstract] [Full Text] [Related]
5. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Langlet C, Springael C, Johnson J, Thomas S, Flamand V, Leitges M, Goldman M, Aksoy E, Willems F. Eur J Immunol; 2010 Feb 01; 40(2):505-15. PubMed ID: 19950169 [Abstract] [Full Text] [Related]
7. Human monocytoid cells as a model to study Toll-like receptor-mediated activation. Remer KA, Brcic M, Sauter KS, Jungi TW. J Immunol Methods; 2006 Jun 30; 313(1-2):1-10. PubMed ID: 16720029 [Abstract] [Full Text] [Related]
10. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, Gretz N, Schaefer L, Kirschning CJ, Popovic ZV, Gröne HJ. Dis Model Mech; 2010 Jun 30; 3(1-2):92-103. PubMed ID: 20038715 [Abstract] [Full Text] [Related]
12. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. Velayudham A, Hritz I, Dolganiuc A, Mandrekar P, Kurt-Jones E, Szabo G. J Hepatol; 2006 Dec 30; 45(6):813-24. PubMed ID: 16935388 [Abstract] [Full Text] [Related]
13. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, Beutler B. Nature; 2003 Aug 14; 424(6950):743-8. PubMed ID: 12872135 [Abstract] [Full Text] [Related]
14. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K. Int Immunol; 2007 Mar 14; 19(3):311-20. PubMed ID: 17289654 [Abstract] [Full Text] [Related]
15. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes. Romics L, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, Golenbock D, Kurt-Jones E, Szabo G. J Leukoc Biol; 2005 Dec 14; 78(6):1255-64. PubMed ID: 16204620 [Abstract] [Full Text] [Related]
16. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Lee JK, Kim SY, Kim YS, Lee WH, Hwang DH, Lee JY. Biochem Pharmacol; 2009 Apr 15; 77(8):1391-400. PubMed ID: 19426678 [Abstract] [Full Text] [Related]
17. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Youn HS, Saitoh SI, Miyake K, Hwang DH. Biochem Pharmacol; 2006 Jun 28; 72(1):62-9. PubMed ID: 16678799 [Abstract] [Full Text] [Related]
18. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. Schmitz F, Mages J, Heit A, Lang R, Wagner H. Eur J Immunol; 2004 Oct 28; 34(10):2863-73. PubMed ID: 15368303 [Abstract] [Full Text] [Related]
19. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. de Vos AF, Pater JM, van den Pangaart PS, de Kruif MD, van 't Veer C, van der Poll T. J Immunol; 2009 Jul 01; 183(1):533-42. PubMed ID: 19542464 [Abstract] [Full Text] [Related]
20. Anti-β(2)GPI/β(2)GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways. Xie H, Zhou H, Wang H, Chen D, Xia L, Wang T, Yan J. Mol Immunol; 2013 Mar 01; 53(3):246-54. PubMed ID: 22964479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]